Summit Therapeutics Inc. (SMMT)
NASDAQ·Healthcare·Biotechnology
$12.86
+2.47%
Mkt Cap $10.60B
Analyst Ratings
Buy
6
Hold
4
Sell
0
Price Target (20 analysts)
$19.50
Range $16.00 – $23.00
Implied Upside
+51.6%
Consensus $19.50 vs current $12.86
NASDAQ·Healthcare·Biotechnology
$12.86
+2.47%
Mkt Cap $10.60B
Buy
6
Hold
4
Sell
0
Price Target (20 analysts)
$19.50
Range $16.00 – $23.00
+51.6%
Consensus $19.50 vs current $12.86